ArticleSurgery2024

Gastroenteropancreatic neuroendocrine carcinoma tumor spheroid drug screen reveals vulnerability to tyrosyl-DNA phosphodiesterase 1 inhibitors.

Gabriella V Beyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.